| ASSET | YEAR | % RETURN |
|---|---|---|
Apellis Pharmaceuticals (APLS) | 2017 | 49.66% |
Apellis Pharmaceuticals (APLS) | 2018 | -39.27% |
Apellis Pharmaceuticals (APLS) | 2019 | 137.18% |
Apellis Pharmaceuticals (APLS) | 2020 | 84.75% |
Apellis Pharmaceuticals (APLS) | 2021 | -17.4% |
Apellis Pharmaceuticals (APLS) | 2022 | 9.3% |
Apellis Pharmaceuticals (APLS) | 2023 | 18.07% |
Apellis Pharmaceuticals (APLS) | 2024 | -46.72% |
Apellis Pharmaceuticals (APLS) | 2025 | -46.01% |
